LUNA 3D
Lap GmbH Laser Applikationen · Decision date Jun 4, 2026
What did the FDA decide?
FDA records K253004 as a 510(k) premarket notification, with a decision dated Jun 4, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Jun 4, 2026
Regulatory record facts
- Identifier
- K253004
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Lap GmbH Laser Applikationen
- Product code
- IYE
- Decision code
- SESE
- Decision date
- Jun 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Accelerator, Linear, Medical.
- Applicant
- Lap GmbH Laser Applikationen
- Product code
- IYE
- FDA device class
- 2
FDA decision timeline
K253004 received
Application receipt date recorded by FDA.
K253004 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Stabilix, LLC | 510(k) clearance | Sep 16, 2026 | FDA | |
EZFluence (RADEZ V2)K261718 | Radformation, Inc. | 510(k) clearance | Aug 31, 2026 | FDA |
| Manteia Technologies Co., Ltd. | 510(k) clearance | Aug 26, 2026 | FDA | |
| Varian Medical Systems, Inc. | 510(k) clearance | Aug 3, 2026 | FDA | |
ThinkQA 3K252937 | Dosisoft SA | 510(k) clearance | Jun 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Lap GmbH Laser Applikationen
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Lüneburg
Sources and methodology
- Original FDA record: K253004
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



